OVID icon

Ovid Therapeutics
OVID

Overview Fund Trends Analyst Outlook Journalist POV

45 hedge funds and large institutions have $81.8M invested in Ovid Therapeutics in 2017 Q2 according to their latest regulatory filings, with 45 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
45
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$18.3M
2
+$11.8M
3
+$6.74M
4
TCM
Tekla Capital Management
Massachusetts
+$5.23M
5
O
OppenheimerFunds
New York
+$4.46M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$210K
27
$204K
28
$193K
29
$189K
30
$153K
31
$142K
32
$135K
33
$128K
34
$93K
35
$83K
36
$64K
37
$53K
38
$33K
39
$30K
40
$15K
41
$11K
42
$5.56K
43
$5K
1
2